$IDRA Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$IDRA Up to date company activities and other important information about $IDRA

$IDRA

DD Notes ~ http://www.ddnotesmaker.com/IDRA

##### recent news/filings ~ source: finance.yahoo.com

Fri, 13 Dec 2013 21:25:44 GMT ~ IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
read full: http://biz.yahoo.com/e/131213/idra8-k.html
*********************************************************

Wed, 04 Dec 2013 13:20:26 GMT ~ Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenström’s Macroglobulinemia
- Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenström's Macroglobulinemia - IMO-8400 Targets An Oncogenic Mutation Present in Most Waldenström's Macroglobulinemia ...
read full: http://www.noodls.com/view/219FAAEF9526970799...7AD9CF321D
*********************************************************

Wed, 04 Dec 2013 12:30:00 GMT ~ Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenström’s Macroglobulinemia
- Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström’s macroglobulinemia, following acceptance of its Investigational New Drug application ...
read full: http://finance.yahoo.com/news/idera-pharmaceu...00547.html
*********************************************************

Mon, 25 Nov 2013 22:08:06 GMT ~ Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 25, 2013-- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune ...
read full: http://www.noodls.com/view/0333D04A354C539560...04A9E54FE0
*********************************************************

Mon, 25 Nov 2013 21:02:00 GMT ~ Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
- Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that Sudhir Agrawal, D.
read full: http://finance.yahoo.com/news/idera-pharmaceu...00655.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=IDRA&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=IDRA&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/IDRA/company-info
Ticker: $IDRA
OTC Market Place: Not Available
CIK code: 0000861838
Company name: Idera Pharmaceuticals, Inc.
Company website: http://www.iderapharma.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/IDRA/filings
Latest financials: http://www.otcmarkets.com/stock/IDRA/financials
Latest news: http://www.otcmarkets.com/stock/IDRA/news - http://finance.yahoo.com/q/h?s=IDRA+Headlines

Major holdings: http://data.cnbc.com/quotes/IDRA/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=IDRA+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/IDRA.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=IDRA

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Idera+Pharmaceutic...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.iderapharma.com
Alexa: http://www.alexa.com/siteinfo/http://www.iderapharma.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.iderapharma.com

http://www.pennystocktweets.com/stocks/profile/IDRA

##### last known share structure ~ source: otcmarkets.com

Market Value: $141,391,986 a/o Dec 13, 2013
Shares Outstanding: 63,690,084 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001

##### business description ~ source: otcmarkets.com

IC

DD Notes ~ http://www.ddnotesmaker.com/IDRA

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading